1. Home
  2. ATRC vs CENX Comparison

ATRC vs CENX Comparison

Compare ATRC & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • CENX
  • Stock Information
  • Founded
  • ATRC 2000
  • CENX 1995
  • Country
  • ATRC United States
  • CENX United States
  • Employees
  • ATRC N/A
  • CENX N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • CENX Aluminum
  • Sector
  • ATRC Health Care
  • CENX Industrials
  • Exchange
  • ATRC Nasdaq
  • CENX Nasdaq
  • Market Cap
  • ATRC 1.6B
  • CENX 1.9B
  • IPO Year
  • ATRC 2005
  • CENX 1996
  • Fundamental
  • Price
  • ATRC $32.96
  • CENX $17.46
  • Analyst Decision
  • ATRC Strong Buy
  • CENX Strong Buy
  • Analyst Count
  • ATRC 10
  • CENX 3
  • Target Price
  • ATRC $48.50
  • CENX $23.00
  • AVG Volume (30 Days)
  • ATRC 639.5K
  • CENX 1.7M
  • Earning Date
  • ATRC 04-30-2025
  • CENX 04-30-2025
  • Dividend Yield
  • ATRC N/A
  • CENX N/A
  • EPS Growth
  • ATRC N/A
  • CENX N/A
  • EPS
  • ATRC N/A
  • CENX 3.27
  • Revenue
  • ATRC $465,307,000.00
  • CENX $2,220,300,000.00
  • Revenue This Year
  • ATRC $14.60
  • CENX $7.73
  • Revenue Next Year
  • ATRC $12.58
  • CENX $7.23
  • P/E Ratio
  • ATRC N/A
  • CENX $5.69
  • Revenue Growth
  • ATRC 16.55
  • CENX 1.60
  • 52 Week Low
  • ATRC $18.94
  • CENX $11.40
  • 52 Week High
  • ATRC $43.11
  • CENX $25.39
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 42.27
  • CENX 40.10
  • Support Level
  • ATRC $31.02
  • CENX $17.27
  • Resistance Level
  • ATRC $34.30
  • CENX $18.74
  • Average True Range (ATR)
  • ATRC 1.74
  • CENX 0.95
  • MACD
  • ATRC 0.07
  • CENX -0.15
  • Stochastic Oscillator
  • ATRC 42.08
  • CENX 9.38

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

Share on Social Networks: